Novacea

Industry · 10 registered clinical trials.

Status	Trial	Phase	Started
Suspended	A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Adva Pancreatic Cancer	Phase 2	2007-09-01
Unknown	AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiform Glioblastoma Multiforme	Phase 1 / Phase 2	2006-10-01
Unknown	Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004 Androgen Independent Prostate Cancer (AIPC), Non Small Cell Lung Cancer (NSCLC)	Phase 2	2006-04-01
Terminated	DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Prostate Cancer	Phase 3	2006-01-01
Unknown	Study of AQ4N in Patients With Non Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Leuk Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia	Phase 1 / Phase 2	2005-03-01
Unknown	Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma Solid Malignancies, Non-Hodgkin's Lymphoma	Phase 1	2004-08-01
Completed	Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer Carcinoma, Non-Small-Cell Lung	Phase 1 / Phase 2	2003-06-01
Unknown	Study of High-Dose Pulse Administration DN-101 (Calcitriol) in Patients With Myelodysplastic Syndrome (MDS) Myelodysplastic Syndrome	Phase 2	2002-11-01
Unknown	ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere Prostate Cancer	Phase 2 / Phase 3	2002-08-01
Completed	A New Formulation of Calcitriol (DN-101) in Patients With Advanced Malignancies Neoplasms	Phase 1	2002-03-01